ABSTRACT
INTRODUCTION
Now-a-days, an increasing number of applications in different fields especially on the field of natural and social sciences produce massive volumes of very high dimensional data under a variety of experimental constrains. In scientific databases like gene microarray dataset [1] , it is common to encounter large sets of observations, represented by hundreds or more of dimensions. Microarray technology [2] allows to simultaneously analyzing thousands or more of genes and thus can give important insights about cell's function, since changes in the composition of an organism are generally associated with changes in gene expression patterns. The availability of massive amounts of experimental data based on genome-wide studies has given momentum in recent years to a large effort in developing mathematical, statistical, and computational techniques to surmise biological models from data. In many bioinformatics problems, number of genes is significantly larger than the number of samples (high gene-to-sample ratio data sets). This is typical of cancer classification tasks where a systematic investigation of the correlation of expression patterns of thousands of genes to specific phenotypic variations is expected to provide an improved catalog of cancer. In this context, the number of features corresponds to the number of expressed gene probes (up to several thousand) and the number of observations to the number of tumor samples (typically on the order of hundreds) is typically correlated.
In DNA microarray data [1] analysis generally biologists measure the expression levels of genes in the tissue samples from patients, and find explanations about how the genes of patients relate to the types of cancers they had. Many genes could strongly be correlated to a particular type of cancer, however, biologists prefer to focal point on a small subset of genes that dominates the outcomes before performing in-depth analysis and expensive experiments with a high dimensional dataset. Therefore, automated selection of the small subset of genes is highly advantageous. DNA microarray technology [2] has directed the focus of computational biology towards analytical data interpretation [3] . However, when examining microarray data, the size of the data sets and noise contained within the data sets compromises precise qualitative and quantitative analysis [4] .
Generally, this field includes two key procedures: important gene identification and classifier construction. The gene selection [5, 6] is particularly crucial in this topic as the number of genes irrelevant to classification may be huge, and hence, accurate prediction can be achieved only by performing gene selection reasonably, that is, identifying most informative genes from a large number of candidates. Once such genes are chosen, the creation of classifiers on the basis of the genes is another mission. Most of the papers [7] [8] [9] obtain accurate classification results based on more than two genes.
In the paper, a novel gene selection and subsequently a suitable classification rule generation technique has been proposed on microarray data for selecting a single important gene to predict cancerous gene with high classification accuracy. The method can be broken down into following four steps:
i.
The gene expression dataset is standardized to Z-score using Transitional State Discrimination method [10] and then discretized to five discrete values. ii.
Since, all genes are not important to identification of particular cancer diseases, a relevance analysis of genes are performed to select only the important genes. As the samples of genes are collected from both normal and cancerous patients, the samples are divided into two disjoint classes. For each gene, frequencies of discrete sample values are computed in each class, based on which importance of the genes is measured. iii.
Since, each gene contains some normal samples and some cancerous samples, traditional k-means clustering algorithm [11] [12] [13] with k =2 is applied on each selected gene and miss-classification accuracy is computed based on which only the most important genes are selected for classification. iv.
Finally, classification rules [7, 14, 15] are generated for each gene on the basis of training dataset to identify cancer and non cancer samples of test dataset and obtained satisfactory accuracy.
The article is organized into four sections. Section 2 describes the proposed gene selection and classification methodology to select only the important genes according to high classification accuracy. The experimental results and performance of the proposed method for a variety of benchmark gene expression datasets is evaluated in Section 3. Finally, conclusions are drawn in Section 4.
GENE SELECTION AND CLASSIFICATION
Conventionally morphological identification of cancer is not always effective as revealed by frequent occurrences of misdiagnoses. Recent molecular biological studies have concerned that cancer was a disease involving dynamic changes in the genome. Moreover, the rapid advances in cancer diagnosis technology have made it possible to simultaneously measure the expression levels of genes of microarray data in a single experiment. This technology has much facilitated the detection of cancerous molecular markers with respect to specified microarray dataset [1] . One current difficulty in interpreting microarray data comes from their innate nature of 'high dimensional large sample size'. Therefore, robust and accurate gene selection methods are required to identify differentially expressed group of genes across different samples, e.g. between cancerous and normal cells. Gene selection is necessary to find out genes, responsible for complex disease which take part in disease network and provide information about disease related genes. Successful gene selection will help to classify different cancer types, lead to a better understanding of genetic signatures in cancers and improve treatment strategies. Although gene selection and cancer classification are two closely related problems, most existing approaches handle them separately by selecting genes prior to classification.
Relevance Analysis of Genes
Let the labeled microarray gene expression dataset MDS = (U, C, D), where U = {g 1 , g 2 , …,g n } is the universe of discourse contained all the genes of the dataset, C = {C 1 , C 2 , …, C m } is C is the condition attribute set contains all the samples and D = {d 1 , d 2 } is the set of decision attributes. The Table1 shows the example of MDS with gene expression values and decision attributes.
Table1. Microarray dataset decision table (genes/samples).
Condition attributes (Samples)
Decision attributes (classes)
Set of Genes
As all genes are not important to identification of particular cancer diseases, a relevance analysis of genes is necessary to select only the important genes. Initially, gene dataset MDS are preprocessed by standardizing the samples to z-score using Transitional State Discrimination method (TSD) [10] . In TSD, discretization factor f ij is computed for sample C j ∈ C of gene g i ∈ U, i = 1, 2, …, n, j = 1, 2, …, m , using (1) .
Where, µ i and δ i are the mean and standard deviation of gene g i and M i [C j ] is the value of sample C j in gene g i . Then mean (N i ) of negative values and mean (P i ) of positive values are computed from ݂ of each gene g i and discretized to one of fuzzy linguistic term [16] and discretized to one of fuzzy linguistic term using (2) .
As the samples of genes are collected from both normal and cancerous patients, so the samples are divided into two disjoint classes say, d 1 and d 2 . Now for each gene, frequencies of discrete sample values are computed in each class. Now for each gene i, maximum frequencies of discrete sample values are computed in each class using (3) and (4), respectively.
Where, Count(x) is the numeric counting amount of maximum frequencies in class d 1 and d 2 for gene g i respectively. If the maximum frequencies of P li and P ri occur for same discrete value, then the gene g i is not so important as both the normal and cancerous samples are almost similar. Otherwise, the sample values of normal and cancerous samples are distinct for gene g i and so the gene is considered as an important gene with importance factor (PF i ) computed using (5) .
Where, i = 1, 2,…, n and m is the total number of samples. So, higher the importance factor more relevant the gene is and vice versa.
Reduct Generation
The measurement of similarity/dissimilarity among the genes based on the distance metric may not be effective for gene data analysis in a high dimensional space. And at the same time, elegant gene selection decreases the workload and simplifies the subsequent design process to a great extent. So, the method proposed a design approach to compute a minimum subset of genes called reduct which can, by itself, fully characterize the knowledge in the gene database as the whole set of genes (U) and preserves partition of data with respect to cancer classification. After computing importance factor of all genes, top n 1 (where, n 1 <<n) number of genes are selected as initial reduct IRED. But in most of the cases, the initial reduct could not classify normal and cancerous samples with high classification accuracy. As a result, some most important genes are selected from initial reduct and form final reduct FRED.
To obtain the final reduct, genes in IRED are partitioned from high dimensional space into lower dimensional space i.e., n 1 numbers of one-dimensional matrices are formed, one for each gene. Since, each gene contains some normal and some cancerous samples, it is expected that the sample values will form two disjoint clusters, one containing normal sample values and other with cancerous sample values. So traditional k-means clustering algorithm [11] [12] [13] with k =2 is applied on the gene and miss-classification accuracy is computed using (6) .
Where, m 1i is the number of d 1 Compute mis-classification accuracy ME i of gene g i using (6) } Arrange ‫ܧܯ‬ in non decreasing order of ME i FRED = set of first n 2 genes, where, n 2 << n 1 End
Classifier Construction
The classifier is an important tool [7, 14, 15] constructed from the nature (i.e., expression values) of selected important gene of training experimental dataset for classification of cancerous and non-cancerous test samples. Here, only a set of most important genes are selected from the gene dataset and kept in FRED and classification rules are generated individually for each of the genes. Classification rules generated are of the form of "x -> y" indicates that "if x, then y", where x is the description on condition attributes or samples and y is the description on decision attributes or types of a gene. Gene is described by the sample values, some from normal and some from cancerous patients. So, two classes say, d 1 (ii) Overlapping intervals: In the case, one interval is not considered as a proper subset of the other, which is described in next case. Here, also without loss of generality, assume that, min 2 < max 1 . So, the range of overlap portion is max 1 -min 2 . The range is not divided equally in this case, rather it is divided based on the number of samples of each class lies in it. If the ratio of percentage of samples of class d 1 to that of class d 2 in the range is m: n, then the value (R) of the point at which the range divided is obtained by (7) or (8) and R is considered as the upper limit of the sample values of normal genes beyond which samples are of cancerous genes as shown in Fig.2 . Fig. 3 , is obtained by (9) or (10) .
Since, class d 2 is fully contained in class d 1 , the value of R may be the upper limit or lower limit of the sample values of class d2 (i.e., cancerous genes) and thus two possible rules are (i) If (min1 <= sample value < R) OR (max2 < sample value <= max1)) then normal samples (ii)
If (R <= sample value <=max2) then cancerous samples OR (iii) If (min1 <= sample value < min2) OR (R < sample value <= max1)) then normal samples If (min2 <= sample value <=R) then cancerous samples Compute R using (7) Compute R using (9) In addition, because there are microarray intensity discrepancies between the training set and the test set in the prostate cancer dataset [19, 20] caused by two different experiments, so normalization is required for both the training and the test dataset. Each original expression level M(i,j) is normalized using (11). After the normalization, all the gene expression levels are limited in interval [-1, 1] . For the other datasets, to avoid unnecessary loss of information, the normalization process is not conducted since the training and the test sets are from the same experiments [17, 18, 21] .
The proposed method, computes firstly initial reduct set IRED of seventy five genes with top probability factors and then final reduct set FRED with fifteen genes with less miss-classification errors. It is observed that all final identified genes of all gene dataset are most important with respect to classification accuracy.
In Leukemia dataset [17] , seven genes with their computed importance factor, mis-classification error and classification accuracy are listed in Table 3 and all other selected genes have the classification accuracy more than 73% (not shown). Two classification rules induced from training dataset by gene index 2288 are: if M(#2288) ≥ 929.5, then AML and if M(#2288) < 929.5, then ALL. Likewise, gene #760 induces two rules: if M (Gene_id_760) ≥ 720.5, then AML and if M (Gene_id_760) < 720.5, then ALL. Similarly, for Lung cancer dataset [18] , similar information are shown in Table 4 for fourteen genes and all other selected genes have the classification accuracy more than 80% (not shown). Similarly, for Prostate cancer dataset [19, 20] , similar information are shown in Table 5 for seven genes and all other selected genes have the classification accuracy more than 75% (not shown). Similarly, for Breast cancer dataset [21] , similar information are shown in Table 6 for seven genes and all other selected genes have the classification accuracy more than 75% (not shown The rules generated for selected genes shown in Table 3 , Table 4 , Table 5 and Table 6 by the proposed classification method and other methods such as Bayes classifier (Naïve Bayes), Tree based classifier (J48-C 0.25 and RandomForest), Rule based classifier (PART), Meta classifier (AdaBoostM1) and Lazy classifier (Kstar) are applied on test samples and accuracies are measured, as shown in Fig. 4, Fig. 5 , Fig. 6 and Fig. 7 . It is observed that for all test-dataset, the proposed and other classifiers shows better accuracy that shows the importance of selected genes. Also in most of the cases, accuracy obtained by the proposed method is higher compare to other methods which show the goodness of the proposed classifier. 
DISCUSSIONS AND CONCLUSIONS
Systematic and unbiased approach to cancer classification is of great importance to cancer treatment and drug discovery. It has been known that gene expression contains the keys to the fundamental problems of cancer diagnosis, cancer treatment and drug discovery. The recent advent of microarray technology has made the production of large amount of gene expression data possible. This has motivated the researchers in proposing different cancer classification algorithms using gene expression data.
In the paper, a novel gene selection and classification technique has been proposed for select important genes (single) and then constructs classification rules to classify cancerous and noncancerous samples with high classification accuracy. The proposed method is applied on four publicly available experimental microarray cancer dataset and selects some important genes by comparing probability factors of all genes and form initial reduct according to proposed algorithm. Then traditional k-means algorithm is applied on initial reduct for each gene and form final reduct with more important genes on consideration of less miss-classification accuracy. Then construct classification rules on the basis of selected genes (single train gene) and classification accuracy in terms of correctly classified instances apply on test genes that shows quantitative satisfactory results. Gene selection, an important preprocessing step was presented in detail and evaluated for their relevance in cancer classification. Comparative study is also made with respect to correctly classified instances (%) by some traditional classifiers namely Bayes, J48, PART, MLP, Random Forest, AdaBoost and Kstar which shows that the goodness of the proposed method.
